Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Identification of markedly decreased CD41 (GPIIb) and CD61 (GPIIIa) expression levels, which are diagnostic for Glanzmann thrombasthenia
Identification of markedly decreased CD42a (GPIX) and CD42b (GPIb-alpha) expression levels, which are diagnostic for Bernard-Soulier syndrome
Identification of decreased GPVI expression, which suggests collagen receptor deficiency
Identification of decreased CD49b (GPIa), which suggests collagen receptor deficiency
This test serves as a confirmatory test for platelet aggregation studies.
Markedly decreased platelet surface glycoprotein expression levels are diagnostic for various hereditary or acquired platelet disorders.
Immunophenotyping